Articles • Apr 25, 2024
Publications
Articles • Apr 23, 2024
Non-Disclosure Agreements (NDAs) in the IP Context – the What, Why, When, and How
Emilie Feil-Fraser There are numerous situations where a non-disclosure...
Articles • Apr 8, 2024
Case Comment – Organigram Inc v Canada (Attorney General), 2023 FC 1075
Update – March 22, 2024: Following the Federal Court’s decision to remit this...
News • Apr 4, 2024
CBA IP Day
CBA IP Day is taking place on May 30th in Ottawa, ON. We are thrilled to...
Articles • Mar 21, 2024
Case review 2023: patent motions
In 2023, the Federal Court of Canada released more patent motion decisions...
News • Mar 7, 2024
2024 Canadian Legal Lexpert Directory
Congratulations to Patrick Smith, Scott Foster and Mat Brechtel for being...
Articles • Feb 22, 2024
Case law update Part 3: IP motions decided in 2023
In 2023, there were 43 reported Federal Court IP motions. The pie chart below...
Articles • Feb 15, 2024 • TOPICS: patent, pmnoc, utility
Trial judge holds dosage patent treating heartburn to be invalid and not infringed
The Federal Court has held a patent covering DEXILANT® (dexlansoprazole) for...
Articles • Feb 14, 2024 • TOPICS: NDS, NOA, patent, pmnoc
Appellate Court confirms a NOA may be transferred to a successor second person on a New Drug Submission
The Federal Court of Appeal confirmed that transfer of a New Drug Submission...
Articles • Jan 26, 2024